New Requests for Applications

ALIGN-T1D is launching two parallel Requests for Applications (RFAs) aimed at increasing co-financing and enhancing market intelligence for global type 1 diabetes (T1D) care, medicines, and technologies.

RFA-A: Catalytic Co-Financing Mechanism

This opportunity funds the design and pilot of a time-bound, conditions-based co-financing mechanism that uses catalytic financing to incentivize domestic investment in insulin and BGM procurement. The goal is to support country partners in transitioning away from donations by aligning donor funding with government procurement systems — improving market competition, affordability, and sustainability.

Key objectives:

  • Expand government-led procurement of insulin and BGM supplies
  • Reduce dependence on fragmented, donation-based models
  • Improve market attractiveness through increased, consolidated procurement volume
  • Create a replicable, scalable model that can be embedded in broader health financing systems
Download RFA-A

RFA-B: Demand Visibility & Market Intelligence Platform

This opportunity funds the development of a cross-country demand visibility and market intelligence platform that gives governments, suppliers, and funders the credible, coordinated information they need to improve procurement planning and market functioning for insulin and diabetes commodities.

Key objectives:

  • Aggregate and analyze demand signals across countries
  • Provide actionable market intelligence to both buyers and suppliers
  • Strengthen procurement planning and forecasting capacity
  • Facilitate structured dialogue between procurers and manufacturers to improve market predictability and supply security
Download RFA-B

Who Should Apply

RFAs are open to a broad range of organizational types, including:

  • Non-governmental organizations (NGOs), including international NGOs (INGOs)
  • Academic and research institutions
  • Universities and institutions of higher education
  • Private sector entities, including for-profit firms and social enterprises
  • Public health institutes and think tanks
  • Consortia comprised of any combination of the above


Note: Intergovernmental organizations (IGOs) — defined as organizations established by treaty or formal agreement among sovereign states or governments — are not eligible to serve as prime applicants but may participate as sub-awardees or consortium partners, subject to funder approval.

If you are interested in future opportunities, please contact us at global@breakthroughT1D.org.

Key Dates

  • Call Released: 7 May 2026
  • Deadline for Questions: 13 May 2026
  • RFA Submission Deadline: 5PM Eastern Daylight Time (21:00 UTC) on 1 June 2026

How to Submit

Submit applications by email to kcaldwell@breakthrought1d.org, with global@breakthrought1d.org copied.

Please format and name files as follows:

  • Narrative: Submit as a Word document (.docx) or PDF
  • Financial Reports: Submit as an Excel spreadsheet (.xlsx)
  • File Naming: Use the format OrganizationName_RFANumber_Application (for example: BreakthroughT1D_RFAB_Application)


If you are applying to both RFAs, submit a separate application for each, unless you are combining both into a single integrated proposal.

Scroll to Top